Diligence memo · auto-generated · as of July 3, 2026

North Texas Renal Management XI, LLC

North Texas Renal Management XI, LLC looks under-valued against its niche peers and is at-risk on financing cadence.

WatchOverdue for a raise versus sector cadence — could be a bridge, a down round, or distress. Watch for the next filing.

Businessfiled

North Texas Renal Management XI, LLC operates in Other Health Care, based in DALLAS.

No verified homepage on file yet — operating evidence is limited to the public record.

Capital & rounds (filed)filed

North Texas Renal Management XI, LLC has raised $771K in disclosed capital across 2 recorded rounds, aggregated from public filings. Its latest round is modeled as Pre-Seed (a round under $1.0M).

Largest single filing: $639K on 2022-07-29.

Most recent recorded round closed around 2023-01-01.

Valuation (modeled)modeled

Provath models North Texas Renal Management XI, LLC at approximately $1.2M (range $82K–$6.2M). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.

Read: Under-valued. Modeled value is 0.46× the median modeled value of Pre-Seed Other Health Care companies in 2022–2024 (288 peers) — value vs value, same stage and era.

Financing rhythm & timingmixed

Historic cadence: a new round about every 5 months.

Last raise 3.5 yr ago; this sector typically re-raises about every 14 months.

Past due for a raise versus sector cadence — watch for distress or a bridge.

The last round was 4.9× smaller than the prior — a bridge or down round.

Comparablesmixed

Capital scale ranks ahead of 29% of Other Health Care peers (5377 compared).

Modeled value ranks above 7% of those peers.

Closest niche peers: Active Recovery TMS, LLC, Imagen Walled Lake Support Services, LLC, Pinnacle Integrated Medicine, Inc., Choix, Inc., DataBiologics, Inc..

Peoplefiled

10 named people on file across officers, directors and signatories.

Risks & flagsmixed

Overdue for a raise versus sector norm — distress or bridge risk.

No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.